Lansforsakringar Fondforvaltning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.8M Sell
172,718
-24,304
-12% -$8.66M 0.32% 59
2025
Q4
$64.5M Buy
197,022
+8,271
+4% +$2.62M 0.32% 53
2025
Q3
$53.3M Buy
188,751
+3,262
+2% +$946K 0.28% 73
2025
Q2
$51.8M Sell
185,489
-14,426
-7% -$4.09M 0.3% 65
2025
Q1
$62.3M Sell
199,915
-2,204
-1% -$651K 0.38% 51
2024
Q4
$52.7M Buy
+202,119
New +$60M 0.29% 65

Other funds holding AMGN

Lansforsakringar Fondforvaltning's AMGN Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $8.66M and leaving 172,718 shares worth $60.8M. The position accounts for 0.32% of the portfolio, ranked #59.

Lansforsakringar Fondforvaltning first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $64.5M in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 172,718 shares of Amgen worth $60.8M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 24,304 Amgen shares in Q1 2026, an estimated $8.66M.
  • Amgen made up 0.32% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #59 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Amgen position peaked at $64.5M in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.